Text Size

Comparison of Two Experimental Mouse Dry Eye Models through Inflammatory Gene Set Enrichment Analysis Based on a Multiplexed Transcriptomic Approach

Kessal K, Daull P, Cimbolini N, Feraille L, Grillo S, Docquier M, Baudouin C, Brignole-Baudouin F, Garrigue JS.


  • 2021
  • International journal of molecular sciences
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Preclinical development

  • Affiliations

    INSERM UMR 968, CNRS UMR 7210, Institut de la Vision, IHU ForeSight, Sorbonne Université UM80,75012 Paris, France; Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC1423, IHU FOReSight, 75012 Paris, France; Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Service 3, 75012 Paris, France. SANTEN SAS, Ophthalmic Innovation Center, 91000 Evry-Couronnes, France; Iris Pharma SAS, 06610 La Gaude, France; iGE3 Genomics Platform, Figu Medical School, University of Geneva, CH-1211 Geneva, Switzerland; Ambroise Paré, APHP, Department of Ophthalmology, University Paris Saclay, 92100 Boulogne, France; Faculté de Pharmacie, Université de Paris, 75006 Paris, France.

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.


Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.


Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P,  Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022